Moderna’s mRNA Flu Vaccine Gets FDA Approval | Lincoln News

Moderna just got FDA approval for its groundbreaking mRNA flu vaccine—targeting folks 50 and older—and it’s a game-changer: the first mRNA flu shot ever approved, boasting 64% effectiveness in trials. Unlike traditional flu vaccines, it trains your body to make its own antibodies using cutting-edge tech. With over 35,000 participants in the study, Moderna’s aiming to roll it out before flu season hits, while also eyeing head-to-head comparisons with Pfizer’s high-dose version. The company projects $776 million in sales by 2025 and is targeting major market share by 2027. This milestone proves mRNA’s potential beyond COVID—and could reshape how we prevent seasonal illnesses forever. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/955dda0734a812bb